Recorded Chinese product: 硫酸鱼精蛋白注射液硫酸鱼精蛋白注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

注射用水是一种在国家药监局注册认定的药品。该药品含有注射用水、鱼精蛋白-3379d94d等成分。

该药品关联的活性成分包括:注射用水、鱼精蛋白Yujing Danbai。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:上海第一生化药业有限公司Chinese legal name: 上海第一生化药业有限公司。

您可以探索含有相同成分的其他药品:注射用水-4ef6f8fd成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 硫酸鱼精蛋白注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 鱼精蛋白Yujing Danbai.

Manufacturers recorded for this product: 上海第一生化药业有限公司Chinese legal name: 上海第一生化药业有限公司.

Explore other medicines containing the same ingredient: products containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 硫酸鱼精蛋白注射液Recorded Chinese product: 硫酸鱼精蛋白注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 5ml:50mg5 mL:50 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 上海第一生化药业有限公司Chinese legal name: 上海第一生化药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H31020515

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H31020515

Manufacturer

Chinese legal name: 上海第一生化药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H31020515

生产企业

上海第一生化药业有限公司(国产)

适应症

抗肝素药。用于因注射肝素过量所引起的出血。

用法用量

静注:抗肝素过量,用量与最后1次肝素使用量相当(1mg硫酸鱼精蛋白可中和100单位肝素)。每次不超过5ml(50mg)。缓慢静注。一般以每分钟0.5ml的速度静注,在10分钟内注入量以不超过50mg为度。由于本品自身具有抗凝作用,因此2小时内(即本品作用有效持续时间内)不宜超过lOOmg。除非另有确凿依据,不得加大剂量。

不良反应

(1)本品可引起心动过缓、胸闷、呼吸困难及血压降低,大多因静注过快所致,系药物直接作用于心肌或周围血管扩张引起;也有肺动脉高压或高血压的报道。(2)注射后有恶心呕吐、面红潮热及倦怠,如作用短暂,毋需治疗。(3)偶有过敏。

禁忌

对本品过敏者禁用。

注意事项

1.本品易破坏,口服无效。禁与碱性物质接触。2.静脉注射速度过快可致热感、皮肤发红,低血压心动过缓等。3.注射器具不能带有碱性。4.本品过敏反应少,但对鱼类过敏者应用时应注意。

贮藏

密闭,在凉暗处(避光并不超过20℃)保存。

规格

5ml:50mg

证据Evidence

  • 批准文号: 国药准字H31020515
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.